- Home
- BGLC vs GSIW Comparison
BGLC vs GSIW Comparison
Compare BGLC & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- GSIW
- Stock Information
- Founded
- BGLC 2017
- GSIW 2016
- Country
- BGLC Malaysia
- GSIW Hong Kong
- Employees
- BGLC N/A
- GSIW N/A
- Industry
- BGLC Medical Specialities
- GSIW
- Sector
- BGLC Health Care
- GSIW
- Exchange
- BGLC Nasdaq
- GSIW Nasdaq
- Market Cap
- BGLC 7.8M
- GSIW 8.1M
- IPO Year
- BGLC N/A
- GSIW 2023
- Fundamental
- Price
- BGLC $4.39
- GSIW $0.15
- Analyst Decision
- BGLC
- GSIW
- Analyst Count
- BGLC 0
- GSIW 0
- Target Price
- BGLC N/A
- GSIW N/A
- AVG Volume (30 Days)
- BGLC 126.1K
- GSIW 1.7M
- Earning Date
- BGLC 11-14-2025
- GSIW 01-01-0001
- Dividend Yield
- BGLC N/A
- GSIW N/A
- EPS Growth
- BGLC N/A
- GSIW N/A
- EPS
- BGLC N/A
- GSIW N/A
- Revenue
- BGLC $9,465,006.00
- GSIW $5,368,221.00
- Revenue This Year
- BGLC N/A
- GSIW N/A
- Revenue Next Year
- BGLC N/A
- GSIW N/A
- P/E Ratio
- BGLC N/A
- GSIW N/A
- Revenue Growth
- BGLC 2.21
- GSIW 283.23
- 52 Week Low
- BGLC $2.01
- GSIW $0.09
- 52 Week High
- BGLC $15.60
- GSIW $1.79
- Technical
- Relative Strength Index (RSI)
- BGLC 37.35
- GSIW 48.37
- Support Level
- BGLC $4.35
- GSIW $0.14
- Resistance Level
- BGLC $4.94
- GSIW $0.15
- Average True Range (ATR)
- BGLC 0.28
- GSIW 0.01
- MACD
- BGLC -0.06
- GSIW -0.00
- Stochastic Oscillator
- BGLC 11.24
- GSIW 22.06
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.